125 related articles for article (PubMed ID: 31478152)
1. Predominant neurological phenotype in a Hungarian family with two novel mutations in the XPA gene-case series.
Zádori D; Szpisjak L; Németh IB; Reisz Z; Kovacs GG; Szépfalusi N; Németh VL; Maróti Z; Tóth-Molnár E; Oláh J; Vécsei L; Klivényi P; Kalmár T
Neurol Sci; 2020 Jan; 41(1):125-129. PubMed ID: 31478152
[TBL] [Abstract][Full Text] [Related]
2. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
[TBL] [Abstract][Full Text] [Related]
3. Genetic investigation of XPA gene: high frequency of the c.682C>T mutation in Moroccan XP patients with moderate clinical profile.
Kindil Z; Senhaji MA; Bakhchane A; Charoute H; Chihab S; Nadifi S; Barakat A
BMC Res Notes; 2017 Dec; 10(1):704. PubMed ID: 29208038
[TBL] [Abstract][Full Text] [Related]
4. Severe phenotypes in two Tunisian families with novel XPA mutations: evidence for a correlation between mutation location and disease severity.
Messaoud O; Rekaya MB; Ouragini H; Benfadhel S; Azaiez H; Kefi R; Gouider-Khouja N; Mokhtar I; Amouri A; Boubaker MS; Zghal M; Abdelhak S
Arch Dermatol Res; 2012 Mar; 304(2):171-6. PubMed ID: 22081045
[TBL] [Abstract][Full Text] [Related]
5. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
6. Neurological manifestations of xeroderma pigmentosum due to
Salomão RPA; Pedroso JL; Barsottini OGP
Pract Neurol; 2018 Dec; 18(6):489-491. PubMed ID: 30077970
[No Abstract] [Full Text] [Related]
7. Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.
Garcia-Moreno H; Langbehn DR; Abiona A; Garrood I; Fleszar Z; Manes MA; Morley AMS; Craythorne E; Mohammed S; Henshaw T; Turner S; Naik H; Bodi I; Sarkany RPE; Fassihi H; Lehmann AR; Giunti P
Brain; 2023 Dec; 146(12):5044-5059. PubMed ID: 38040034
[TBL] [Abstract][Full Text] [Related]
8. An XPA gene splicing mutation resulting in trace protein expression in an elderly patient with xeroderma pigmentosum group A without neurological abnormalities.
Takahashi Y; Endo Y; Kusaka-Kikushima A; Nakamaura S; Nakazawa Y; Ogi T; Uryu M; Tsuji G; Furue M; Moriwaki S
Br J Dermatol; 2017 Jul; 177(1):253-257. PubMed ID: 27603812
[TBL] [Abstract][Full Text] [Related]
9. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of brain atrophy in patients with xeroderma pigmentosum group A carrying the founder mutation in Japan.
Ueda T; Kanda F; Nishiyama M; Nishigori C; Toda T
J Neurol Sci; 2017 Oct; 381():103-106. PubMed ID: 28991657
[TBL] [Abstract][Full Text] [Related]
11. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.
Tamhankar PM; Iyer SV; Ravindran S; Gupta N; Kabra M; Nayak C; Kura M; Sanghavi S; Joshi R; Chennuri VS; Khopkar U
Indian J Dermatol Venereol Leprol; 2015; 81(1):16-22. PubMed ID: 25566891
[TBL] [Abstract][Full Text] [Related]
12. Xeroderma pigmentosum: low prevalence of germline XPA mutations in a Brazilian XP population.
Santiago KM; França de Nóbrega A; Rocha RM; Rogatto SR; Achatz MI
Int J Mol Sci; 2015 Apr; 16(4):8988-96. PubMed ID: 25913378
[TBL] [Abstract][Full Text] [Related]
13. [Siblings with xeroderma pigmentosum group A showing mild cutaneous and various neurological manifestations].
Kuru S; Yasuma M; Sakai M; Konagaya M; Moriwaki S
Rinsho Shinkeigaku; 2006 Feb; 46(2):134-9. PubMed ID: 16619838
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlation of xeroderma pigmentosum in a Chinese Han population.
Sun Z; Zhang J; Guo Y; Ni C; Liang J; Cheng R; Li M; Yao Z
Br J Dermatol; 2015 Apr; 172(4):1096-102. PubMed ID: 25256075
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
16. In silico characterization of a novel pathogenic deletion mutation identified in XPA gene in a Pakistani family with severe xeroderma pigmentosum.
Nasir M; Ahmad N; Sieber CM; Latif A; Malik SA; Hameed A
J Biomed Sci; 2013 Sep; 20(1):70. PubMed ID: 24063568
[TBL] [Abstract][Full Text] [Related]
17. XPA gene mutations resulting in subtle truncation of protein in xeroderma pigmentosum group A patients with mild skin symptoms.
Takahashi Y; Endo Y; Sugiyama Y; Inoue S; Iijima M; Tomita Y; Kuru S; Takigawa M; Moriwaki S
J Invest Dermatol; 2010 Oct; 130(10):2481-8. PubMed ID: 20574439
[TBL] [Abstract][Full Text] [Related]
18. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation in the XPA gene results in two truncated protein variants and leads to a severe XP/neurological symptoms phenotype.
Lehmann J; Schubert S; Schäfer A; Laspe P; Haenssle HA; Ohlenbusch A; Gratchev A; Emmert S
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2479-82. PubMed ID: 25393472
[TBL] [Abstract][Full Text] [Related]
20. A novel 5 nucleotide deletion in XPA gene is associated with severe neurological abnormalities.
Ghafouri-Fard S; Fardaei M; Miryounesi M
Gene; 2016 Jan; 576(1 Pt 2):379-80. PubMed ID: 26302748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
